Word: transplant
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
SURVIVORS An experimental bone-marrow transplant may help treat kidney cancer, a disease so virulent that once it spreads, it kills half its victims within a year. Stem cells--the primordial cells that give rise to new cell lines--are collected from bone marrow. Once transplanted, they generate a new immune system, one that's capable of fighting off the cancer. The technique has been tried on only 19 patients, all terminally ill, but the results are promising. Although 10 died, two from the treatment itself, the others saw their malignancy shrink or completely disappear...
Scott's is the first hand transplant of its type in the U.S. and one of only eight worldwide. (Reattaching a patient's own severed hand is far more common.) So far, his transplant team, led by Dr. Warren Breidenbach, at the University of Louisville School of Medicine, and Dr. Jon Jones, now at the Carolinas Medical Center in Charlotte, N.C., seems to have overcome the most formidable challenge of such a procedure--long-term limb rejection. While immune-suppressant drugs have improved the success rate of all kinds of organ transplants, the arm is composed of several different tissues...
...pension check or wanted Gore to call back and pray with them. Once someone stopped the 36-year-old Congressman in a grocery-store parking lot with 11-year-old Karenna at his side. The constituent wanted to thank him for making it easier to get an organ transplant. "I was at that moment struck by how he really impacted people," she says...
...Richard's brain in that body, and she might have won. (I shudder at the thought of that transplant, but she might have.) But Colleen was just cruising through this thing, smiling and tossing her head and dispensing slow-dawning but solid wisdom on the tiny island's Big Picture. On the trivia challenge: "I thought, 'This is gonna be so cool, just like a game show.' Then I was like, 'Wait a minute, we're ON a game show...
DuPont isn't the only company throwing tacks in the path of its generic rivals. Just last week Novartis, maker of the blockbuster anti-rejection drug Neoral, for organ-transplant patients, failed to get a Massachusetts state drug board to limit sales of Neoral's equivalent, generic cyclosporine. Ohio's senate, egged on by Novartis, has held 11 hearings in two years on this issue. "They have been bloody dogged on this," says R.J. Tesi, an executive with generic cyclosporine maker SangStat Medical Corp. He points out that patients spend $5,000 or more on Neoral yearly, while the generic...